wegovy novo nordisk - Search News

News

Novo Nordisk shares plummet

Reuters on MSN · 2d

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market.

CNBC on MSN · 2d

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

The Wall Street Journal on MSN · 2d

Novo Nordisk Shares Plummet as Wegovy Knockoffs Weigh on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

1don MSN

Novo Nordisk slides further on US competition, new CEO concerns

Pedersen and Maggie Fick COPENHAGEN (Reuters) -Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts ...

10hon MSN

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors ...

1d

Obesity Drugmaker Novo Nordisk Plunges as It Cuts Forecasts Again

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk on Tuesday cut its full-year sales and operating profit forecasts for ...

2don MSN

Novo's new CEO faces sceptical investors with Wegovy US sales in focus

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...

2don MSN

Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

2don MSN

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

1d

Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results